{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T00:26:01Z","timestamp":1786753561376,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T00:00:00Z","timestamp":1634083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T00:00:00Z","timestamp":1634083200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>To evaluate the effects of pretreatment for dry eye disease (DED) on the accuracy of intraocular lens (IOL) power calculation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Patients who underwent uneventful cataract surgery were included in the study. IOL power was determined using the SRK\/T and Barrett Universal II (Barrett) formulas. The patients were divided into non-pretreatment and pretreatment groups, and those in the pretreatment group were treated with topical 0.5% loteprednol etabonate and 0.05% cyclosporin A for 2\u2009weeks prior to cataract surgery. Ocular biometry was performed in all groups within 2\u2009days before surgery. The mean prediction error, mean absolute error (MAE), and proportions of refractive surprise were compared between the non-pretreatment and pretreatment groups at 1\u2009month postoperatively. Refractive surprise was defined as MAE\u2009\u2265\u20090.75D.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In a total of 105 patients, 52 (52 eyes) were in the non-pretreatment group and 53 (53 eyes) in the pretreatment group. The MAE was 0.42\u2009\u00b1\u20090.33, 0.38\u2009\u00b1\u20090.34 (SRK\/T, Barrett) and 0.23\u2009\u00b1\u20090.19, 0.24\u2009\u00b1\u20090.19 in the non-pretreatment and pretreatment groups, respectively (<jats:italic>p<\/jats:italic>\u00a0&lt;\u20090.001\/=0.008). The number of refractive surprises was also significantly lower in the pretreatment group. [non-pretreatment\/pretreatment: 9\/2 (SRK\/T); 8\/1 (Barrett); <jats:italic>p<\/jats:italic>\u00a0=\u20090.024\/0.016]. Pretreatment of DED was related to a reduction in postoperative refractive surprise. [SRK\/T\/Barrett: OR\u2009=\u20090.18\/0.17 (95% CI: 0.05\u20130.71\/0.05\u20130.60), <jats:italic>p<\/jats:italic>\u00a0=\u20090.014\/0.006].<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The accuracy of IOL power prediction can be increased by actively treating DED prior to cataract surgery.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12886-021-02129-5","type":"journal-article","created":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T12:13:35Z","timestamp":1634127215000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Improved accuracy of intraocular lens power calculation by preoperative management of dry eye disease"],"prefix":"10.1186","volume":"21","author":[{"given":"Jinsoo","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mee Kum","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuseung","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hae Jung","family":"Paik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,13]]},"reference":[{"issue":"9","key":"2129_CR1","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/j.jcrs.2013.03.027","volume":"39","author":"HE Gollogly","year":"2013","unstructured":"Gollogly HE, Hodge DO, Sauver JLS, Erie JC. Increasing incidence of cataract surgery: population-based study. J Cataract Refract Surg. 2013;39(9):1383\u20139.","journal-title":"J Cataract Refract Surg"},{"issue":"3","key":"2129_CR2","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.jcrs.2014.06.033","volume":"41","author":"A Abulafia","year":"2015","unstructured":"Abulafia A, Barrett GD, Rotenberg M, Kleinmann G, Levy A, Reitblat O, et al. Intraocular lens power calculation for eyes with an axial length greater than 26.0 mm: comparison of formulas and methods. J Cataract Refract Surg. 2015;41(3):548\u201356.","journal-title":"J Cataract Refract Surg"},{"issue":"5","key":"2129_CR3","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/S0886-3350(13)80774-2","volume":"16","author":"T Olsen","year":"1990","unstructured":"Olsen T, Olesen H, Thim K, Corydon L. Prediction of postoperative intraocular lens chamber depth. J Cataract Refract Surg. 1990;16(5):587\u201390.","journal-title":"J Cataract Refract Surg"},{"issue":"4","key":"2129_CR4","doi-asserted-by":"publisher","first-page":"387","DOI":"10.5301\/ejo.5000978","volume":"27","author":"SY Wang","year":"2017","unstructured":"Wang SY, Stem MS, Oren G, Shtein R, Lichter PR. Patient-centered and visual quality outcomes of premium cataract surgery: a systematic review. Eur J Ophthalmol. 2017;27(4):387\u2013401.","journal-title":"Eur J Ophthalmol"},{"issue":"3","key":"2129_CR5","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3341\/kjo.2014.28.3.197","volume":"28","author":"JY Hyon","year":"2014","unstructured":"Hyon JY, Kim H-M, Lee D, Chung E-S, Song J-S, Choi CY, et al. Korean guidelines for the diagnosis and management of dry eye: development and validation of clinical efficacy. Korean J Ophthalmol. 2014;28(3):197.","journal-title":"Korean J Ophthalmol"},{"issue":"3","key":"2129_CR6","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","volume":"15","author":"JP Craig","year":"2017","unstructured":"Craig JP, Nichols KK, Akpek EK, Caffery B, Dua HS, Joo C-K, et al. TFOS DEWS II definition and classification report. Ocul Surf. 2017;15(3):276\u201383.","journal-title":"Ocul Surf"},{"issue":"2","key":"2129_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S1542-0124(12)70082-4","volume":"5","author":"A Janine","year":"2007","unstructured":"Janine A. The epidemiology of dry eye disease: report of the epidemiological subcommittee of the international dry eye workshop. Ocul Surf. 2007;5(2):93\u2013107.","journal-title":"Ocul Surf"},{"key":"2129_CR8","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1097\/ICO.0b013e31812f67ca","volume":"26","author":"X-M Li","year":"2007","unstructured":"Li X-M, Hu L, Hu J, Wang W. Investigation of dry eye disease and analysis of the pathogenic factors in patients after cataract surgery. Cornea. 2007;26:S16\u201320.","journal-title":"Cornea"},{"issue":"2","key":"2129_CR9","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3341\/kjo.2009.23.2.65","volume":"23","author":"YK Cho","year":"2009","unstructured":"Cho YK, Kim MS. Dry eye after cataract surgery and associated intraoperative risk factors. Korean J Ophthalmol. 2009;23(2):65.","journal-title":"Korean J Ophthalmol"},{"issue":"5","key":"2129_CR10","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.jcrs.2019.03.023","volume":"45","author":"CE Starr","year":"2019","unstructured":"Starr CE, Gupta PK, Farid M, Beckman KA, Chan CC, Yeu E, et al. An algorithm for the preoperative diagnosis and treatment of ocular surface disorders. J Cataract Refract Surg. 2019;45(5):669\u201384.","journal-title":"J Cataract Refract Surg"},{"issue":"8","key":"2129_CR11","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1016\/j.jcrs.2015.01.016","volume":"41","author":"AT Epitropoulos","year":"2015","unstructured":"Epitropoulos AT, Matossian C, Berdy GJ, Malhotra RP, Potvin R. Effect of tear osmolarity on repeatability of keratometry for cataract surgery planning. J Cataract Refract Surg. 2015;41(8):1672\u20137.","journal-title":"J Cataract Refract Surg"},{"key":"2129_CR12","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.2147\/OPTH.S264520","volume":"14","author":"J Hovanesian","year":"2020","unstructured":"Hovanesian J, Epitropoulos A, Donnenfeld ED, Holladay JT. The effect of lifitegrast on refractive accuracy and symptoms in dry eye patients undergoing cataract surgery. Clin Ophthalmol (Auckland, NZ). 2020;14:2709.","journal-title":"Clin Ophthalmol (Auckland, NZ)"},{"key":"2129_CR13","doi-asserted-by":"publisher","first-page":"759","DOI":"10.2147\/OPTH.S300047","volume":"15","author":"KJ Ryu","year":"2021","unstructured":"Ryu KJ, Kim S, Kim MK, Paik HJ, Kim DH. Short-term therapeutic effects of topical corticosteroids on refractory dry eye disease: Clinical usefulness of matrix metalloproteinase 9 testing as a response prediction marker. Clin Ophthalmol (Auckland, NZ). 2021;15:759.","journal-title":"Clin Ophthalmol (Auckland, NZ)"},{"issue":"7","key":"2129_CR14","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.exger.2012.03.020","volume":"47","author":"J Ding","year":"2012","unstructured":"Ding J, Sullivan DA. Aging and dry eye disease. Exp Gerontol. 2012;47(7):483\u201390.","journal-title":"Exp Gerontol"},{"issue":"1","key":"2129_CR15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/cxo.12210","volume":"98","author":"LL Tan","year":"2015","unstructured":"Tan LL, Morgan P, Cai ZQ, Straughan RA. Prevalence of and risk factors for symptomatic dry eye disease in Singapore. Clin Exp Optom. 2015;98(1):45\u201353.","journal-title":"Clin Exp Optom"},{"issue":"11","key":"2129_CR16","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1097\/01.opx.0000232814.39651.fa","volume":"83","author":"M Uchino","year":"2006","unstructured":"Uchino M, Dogru M, Yagi Y, Goto E, Tomita M, Kon T, et al. The features of dry eye disease in a Japanese elderly population. Optom Vis Sci. 2006;83(11):797\u2013802.","journal-title":"Optom Vis Sci"},{"issue":"6","key":"2129_CR17","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.ajo.2014.08.021","volume":"158","author":"JM Ahn","year":"2014","unstructured":"Ahn JM, Lee SH, Rim TH, Park RJ, Yang HS, Kim TI, et al. Prevalence of and risk factors associated with dry eye: the Korea National Health and Nutrition Examination Survey 2010\u20132011. Am J Ophthalmol. 2014;158(6):1205\u20131214.e1207.","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"2129_CR18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4082\/kjfm.17.0058","volume":"40","author":"KI Kim","year":"2019","unstructured":"Kim KI, Park YS, Kim RH, Kim JH. Factors associated with dry eye symptoms in elderly Koreans: the fifth Korea national health and nutrition examination survey 2010\u20132012. Korean J Fam Med. 2019;40(1):22.","journal-title":"Korean J Fam Med"},{"issue":"1","key":"2129_CR19","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1001\/archophthalmol.2011.364","volume":"130","author":"W Stevenson","year":"2012","unstructured":"Stevenson W, Chauhan SK, Dana R. Dry eye disease: an immune-mediated ocular surface disorder. Arch Ophthalmol. 2012;130(1):90\u2013100.","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"2129_CR20","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.ajo.2014.02.036","volume":"157","author":"KE Han","year":"2014","unstructured":"Han KE, Yoon SC, Ahn JM, Nam SM, Stulting RD, Kim EK, et al. Evaluation of dry eye and meibomian gland dysfunction after cataract surgery. Am J Ophthalmol. 2014;157(6):1144\u20131150.e1141.","journal-title":"Am J Ophthalmol"},{"key":"2129_CR21","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.2147\/OPTH.S120159","volume":"11","author":"WB Trattler","year":"2017","unstructured":"Trattler WB, Majmudar PA, Donnenfeld ED, McDonald MB, Stonecipher KG, Goldberg DF. The prospective health assessment of cataract patients\u2019 ocular surface (PHACO) study: the effect of dry eye. Clin Ophthalmol (Auckland, NZ). 2017;11:1423.","journal-title":"Clin Ophthalmol (Auckland, NZ)"},{"issue":"2","key":"2129_CR22","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S1542-0124(12)70085-X","volume":"5","author":"SC Pflugfelder","year":"2007","unstructured":"Pflugfelder SC, Geerling G, Kinoshita S, Lemp MA, McCulley JP, Nelson D, et al. Management and therapy of dry eye disease: report of the Management and Therapy Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007;5(2):163\u201378.","journal-title":"Ocul Surf"},{"issue":"1","key":"2129_CR23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2165\/00002018-200225010-00004","volume":"25","author":"CN McGhee","year":"2002","unstructured":"McGhee CN, Dean S, Danesh-Meyer H. Locally administered ocular corticosteroids. Drug Saf. 2002;25(1):33\u201355.","journal-title":"Drug Saf"},{"issue":"8","key":"2129_CR24","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1097\/01.ico.0000214802.40313.fa","volume":"25","author":"A Behrens","year":"2006","unstructured":"Behrens A, Doyle JJ, Stern L, Chuck RS, McDonnell PJ, Azar DT, et al. Dysfunctional tear syndrome: a Delphi approach to treatment recommendations. Cornea. 2006;25(8):900\u20137.","journal-title":"Cornea"},{"issue":"9","key":"2129_CR25","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1111\/j.1442-9071.2009.02134.x","volume":"37","author":"G Fakhraie","year":"2009","unstructured":"Fakhraie G, Lopes JF, Spaeth GL, Almodin J, Ichhpujani P, Moster MR. Effects of postoperative cyclosporine ophthalmic emulsion 0.05%(Restasis) following glaucoma surgery. Clin Exp Ophthalmol. 2009;37(9):842\u20138.","journal-title":"Clin Exp Ophthalmol"},{"issue":"3","key":"2129_CR26","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.ajo.2004.04.052","volume":"138","author":"SC Pflugfelder","year":"2004","unstructured":"Pflugfelder SC, Maskin SL, Anderson B, Chodosh J, Holland EJ, De Paiva CS, et al. A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance. Am J Ophthalmol. 2004;138(3):444\u201357.","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"2129_CR27","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/j.ajo.2014.08.015","volume":"158","author":"H Lee","year":"2014","unstructured":"Lee H, Chung B, Kim KS, Seo KY, Choi BJ. Effects of topical loteprednol etabonate on tear cytokines and clinical outcomes in moderate and severe meibomian gland dysfunction: randomized clinical trial. Am J Ophthalmol. 2014;158(6):1172\u20131183.e1171.","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"2129_CR28","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.jpain.2008.12.001","volume":"10","author":"RB Fillingim","year":"2009","unstructured":"Fillingim RB, King CD, Ribeiro-Dasilva MC, Rahim-Williams B, Riley JL III. Sex, gender, and pain: a review of recent clinical and experimental findings. J Pain. 2009;10(5):447\u201385.","journal-title":"J Pain"},{"key":"2129_CR29","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.2147\/CIA.S140912","volume":"12","author":"JH Ahn","year":"2017","unstructured":"Ahn JH, Choi Y-H, Paik HJ, Kim MK, Wee WR, Kim DH. Sex differences in the effect of aging on dry eye disease. Clin Interv Aging. 2017;12:1331.","journal-title":"Clin Interv Aging"},{"issue":"9","key":"2129_CR30","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.jcrs.2018.06.026","volume":"44","author":"PK Gupta","year":"2018","unstructured":"Gupta PK, Drinkwater OJ, VanDusen KW, Brissette AR, Starr CE. Prevalence of ocular surface dysfunction in patients presenting for cataract surgery evaluation. J Cataract Refract Surg. 2018;44(9):1090\u20136.","journal-title":"J Cataract Refract Surg"},{"issue":"2","key":"2129_CR31","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.jcrs.2017.10.050","volume":"44","author":"B Cochener","year":"2018","unstructured":"Cochener B, Cassan A, Omiel L. Prevalence of meibomian gland dysfunction at the time of cataract surgery. J Cataract Refract Surg. 2018;44(2):144\u20138.","journal-title":"J Cataract Refract Surg"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-021-02129-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-021-02129-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-021-02129-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T12:16:17Z","timestamp":1634127377000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-021-02129-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,13]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2129"],"URL":"https:\/\/doi.org\/10.1186\/s12886-021-02129-5","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,13]]},"assertion":[{"value":"28 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective observational study was conducted in accordance with the tenets of the Declaration of Helsinki, and ethical approval was obtained from the Institutional Review Board of Gachon University Gil Medical Center, Korea (IRB number: GCIRB 2021\u2013170).Need for consent was waived by Review Board of Gachon University Gil Medical Center, Korea (IRB number: GCIRB 2021\u2013170) due to its nature of retrospective study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The author(s) declare(s) that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"364"}}